3
Announcements
Trials
Browse
Landscape
Status
Completed
11
Terminated
2
Withdrawn
1
Recruiting
1
No longer available
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Classical hematology
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Myeloid, Acute
3
Leukemia, Biphenotypic, Acute
3
Lymphoma
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Anemia, Refractory, with Excess of Blasts
2
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoma, T-Cell, Cutaneous
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid
1
Leukemia, Monocytic, Acute
1
Leukemia, Mast-Cell
1
Leukemia, Lymphoid
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, B-Cell
1
Leukemia
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Hematologic Diseases
1
GATA2 Deficiency
1
Burkitt Lymphoma
1
Blastic Plasmacytoid Dendritic Cell Neoplasm
1
Anemia, Sickle Cell
1
Anemia, Aplastic
1
Interventions
venetoclax
27
fludarabine
26
Cyclophosphamide
25
Specimen Handling
21
Azacitidine
20
Biopsy
15
Whole-Body Irradiation
14
Stem Cell Transplantation
13
Decitabine
13
Cytarabine
13
Tacrolimus
12
Melphalan
12
fludarabine phosphate
11
Mycophenolic Acid
11
Busulfan
11
Injections
8
X-Rays
7
Thiotepa
7
Hematopoietic Stem Cell Transplantation
7
Granulocyte Colony-Stimulating Factor
7
decitabine and cedazuridine drug combination
6
Cyclosporine
6
ruxolitinib
5
Magnetic Resonance Spectroscopy
5
Idarubicin
5
Filgrastim
5
gilteritinib
4
Sirolimus
4
Peripheral Blood Stem Cell Transplantation
4
Cyclosporins
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Myelodysplastic Syndromes
×
Bone Marrow Transplantation
×
Clear all
NCT07145411
2025-08-28
HOPE
Ossium Health, Inc.
Recruiting
10 enrolled